When compared to general population, did patients with nonerosive gastroesophageal reflux disease have a similar incidence of esophageal adenocarcinoma?
When compared to general population, did patients with nonerosive gastroesophageal reflux disease have a similar incidence of esophageal adenocarcinoma?
Treatment of eosinophilic esophagitis can go beyond the use of proton pump inhibitors alone, Evan Dellon, MD, stated during his presentation at the ACG Postgraduate Course.
Treatment of eosinophilic esophagitis can go beyond the use of proton pump inhibitors alone, Evan Dellon, MD, stated during his presentation at the ACG Postgraduate Course.
When compared to general population, did patients with nonerosive gastroesophageal reflux disease have a similar incidence of esophageal adenocarcinoma?
When compared to general population, did patients with nonerosive gastroesophageal reflux disease have a similar incidence of esophageal adenocarcinoma?
Dr Dellon gave an oral paper presentation on efficacy and safety data for dupilumab in the treatment of eosinophilic esophagitis at the 2022 ACG Annual Scientific Meeting on October 24.
Dr Dellon gave an oral paper presentation on efficacy and safety data for dupilumab in the treatment of eosinophilic esophagitis at the 2022 ACG Annual Scientific Meeting on October 24.
Intercept Pharmaceuticals will voluntarily withdraw its obeticholic acid product, Ocaliva, from the US market for the treatment of primary biliary cholangitis.
Intercept Pharmaceuticals will voluntarily withdraw its obeticholic acid product, Ocaliva, from the US market for the treatment of primary biliary cholangitis.
A prospective cohort study found that each additional social risk factor significantly increased the likelihood of cancer-specific mortality among patients with advanced colorectal cancer.
A prospective cohort study found that each additional social risk factor significantly increased the likelihood of cancer-specific mortality among patients with advanced colorectal cancer.
Despite significant advances in colorectal cancer screening and treatment, systemic inequities continue to drive higher incidence and mortality rates among Black Americans compared with White individuals, according to a recent review.
Despite significant advances in colorectal cancer screening and treatment, systemic inequities continue to drive higher incidence and mortality rates among Black Americans compared with White individuals, according to a recent review.
Despite national declines in colorectal cancer deaths, a 20-year study finds Black men and residents of Southern and Midwestern states continue to face disproportionately high mortality rates.
Despite national declines in colorectal cancer deaths, a 20-year study finds Black men and residents of Southern and Midwestern states continue to face disproportionately high mortality rates.
Is terminal ileum resection in patients with Crohn’s disease associated with colorectal cancer risk? See what recent research found by taking our quiz.
Is terminal ileum resection in patients with Crohn’s disease associated with colorectal cancer risk? See what recent research found by taking our quiz.
Is there any association between esophageal disorders of gut-brain interaction and refractory reflux symptoms? Test your knowledge with our quick quiz!
Is there any association between esophageal disorders of gut-brain interaction and refractory reflux symptoms? Test your knowledge with our quick quiz!
A prospective study reveals that more than 70% of patients with proven gastroesophageal reflux disease and refractory symptoms also exhibit features of esophageal disorders of gut-brain interaction.
A prospective study reveals that more than 70% of patients with proven gastroesophageal reflux disease and refractory symptoms also exhibit features of esophageal disorders of gut-brain interaction.
The TEMPO trial investigated techniques to improve return rates for fecal immunochemical tests for colorectal cancer. Find out what worked best by taking our quick quiz!
The TEMPO trial investigated techniques to improve return rates for fecal immunochemical tests for colorectal cancer. Find out what worked best by taking our quick quiz!
Research has shown that several social determinants of health (SDOH) are associated with the prevalence of metabolic-associated steatotic liver disease. What has been identified as the most consistent associated SDOH?
Research has shown that several social determinants of health (SDOH) are associated with the prevalence of metabolic-associated steatotic liver disease. What has been identified as the most consistent associated SDOH?
When compared to general population, did patients with nonerosive gastroesophageal reflux disease have a similar incidence of esophageal adenocarcinoma?
When compared to general population, did patients with nonerosive gastroesophageal reflux disease have a similar incidence of esophageal adenocarcinoma?
Dr Dellon gave an oral paper presentation on efficacy and safety data for dupilumab in the treatment of eosinophilic esophagitis at the 2022 ACG Annual Scientific Meeting on October 24.
Dr Dellon gave an oral paper presentation on efficacy and safety data for dupilumab in the treatment of eosinophilic esophagitis at the 2022 ACG Annual Scientific Meeting on October 24.
Intercept Pharmaceuticals will voluntarily withdraw its obeticholic acid product, Ocaliva, from the US market for the treatment of primary biliary cholangitis.
Intercept Pharmaceuticals will voluntarily withdraw its obeticholic acid product, Ocaliva, from the US market for the treatment of primary biliary cholangitis.
A prospective cohort study found that each additional social risk factor significantly increased the likelihood of cancer-specific mortality among patients with advanced colorectal cancer.
A prospective cohort study found that each additional social risk factor significantly increased the likelihood of cancer-specific mortality among patients with advanced colorectal cancer.
Despite significant advances in colorectal cancer screening and treatment, systemic inequities continue to drive higher incidence and mortality rates among Black Americans compared with White individuals, according to a recent review.
Despite significant advances in colorectal cancer screening and treatment, systemic inequities continue to drive higher incidence and mortality rates among Black Americans compared with White individuals, according to a recent review.
Despite national declines in colorectal cancer deaths, a 20-year study finds Black men and residents of Southern and Midwestern states continue to face disproportionately high mortality rates.
Despite national declines in colorectal cancer deaths, a 20-year study finds Black men and residents of Southern and Midwestern states continue to face disproportionately high mortality rates.